Yuki Hasegawa
Direttore/Membro del Consiglio presso NANO MRNA CO.,LTD.
Profilo
Yuki Hasegawa currently works at ActualEyes, Inc., as Director, NANO MRNA Co., Ltd., as Outside Director from 2021, and Whiz Partners, Inc., as Head-Healthcare Investment from 2021.
Posizioni attive di Yuki Hasegawa
Società | Posizione | Inizio |
---|---|---|
NANO MRNA CO.,LTD. | Direttore/Membro del Consiglio | 01/06/2021 |
Whiz Partners, Inc.
Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Investitore di Private Equity | 01/01/2021 |
ActualEyes, Inc.
ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NANO MRNA CO.,LTD. | Health Technology |
Aziende private | 2 |
---|---|
Whiz Partners, Inc.
Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Finance |
ActualEyes, Inc.
ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Technology Services |
- Borsa valori
- Insiders
- Yuki Hasegawa